Hedge Fund - P.A.W. CAPITAL PARTNERS
Eiger Biopharmaceuticals Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $ |
| 2 | 2022 - Q4 (2022-12-31) | $295,000 | 0.8% | 250,000 | $ |
| 3 | 2022 - Q3 (2022-09-30) | $4,066,000 | 6.09% | 540,000 | $ |
| 4 | 2022 - Q2 (2022-06-30) | $3,402,000 | 4.94% | 540,000 | $ |
| 5 | 2022 - Q1 (2022-03-31) | $4,482,000 | 4.68% | 540,000 | $ |
| 6 | 2021 - Q4 (2021-12-31) | $2,595,000 | 2.38% | 500,000 | $ |
| 7 | 2021 - Q3 (2021-09-30) | $2,672,000 | 2.37% | 400,000 | $ |
| 8 | 2021 - Q2 (2021-06-30) | $3,408,000 | 2.86% | 400,000 | $ |
| 9 | 2021 - Q1 (2021-03-31) | $3,363,000 | 2.95% | 380,000 | $ |
| 10 | 2020 - Q4 (2020-12-31) | $4,916,000 | 4.33% | 400,000 | $ |
| 11 | 2020 - Q3 (2020-09-30) | $2,930,000 | 3.18% | 360,000 | $ |
| 12 | 2020 - Q2 (2020-06-30) | $2,880,000 | 3.25% | 300,000 | $ |
| 13 | 2020 - Q1 (2020-03-31) | $2,448,000 | 3.29% | 360,000 | $ |
| 14 | 2019 - Q4 (2019-12-31) | $2,146,000 | 2.28% | 144,000 | $ |
| 15 | 2019 - Q3 (2019-09-30) | $2,050,000 | 2.55% | 200,000 | $ |
| 16 | 2019 - Q2 (2019-06-30) | $2,120,000 | 2.29% | 200,000 | $ |
| 17 | 2019 - Q1 (2019-03-31) | $2,656,000 | 2.62% | 190,000 | $ |
| 18 | 2018 - Q4 (2018-12-31) | $2,235,000 | 2.8% | 220,000 | $ |
| 19 | 2018 - Q3 (2018-09-30) | $420,000 | 0.44% | 35,000 | $ |
| 20 | 2018 - Q2 (2018-06-30) | $1,098,000 | 1.1% | 90,000 | $ |
| 21 | 2018 - Q1 (2018-03-31) | $1,330,000 | 1.59% | 135,000 | $ |
| 22 | 2017 - Q4 (2017-12-31) | $1,395,000 | 1.75% | 100,000 | $ |
| 23 | 2017 - Q3 (2017-09-30) | $880,000 | 0.92% | 80,000 | $ |
The displayed share prices are average quarterly stock market prices.